The Solace European Confirmatory
Trial (SOLECT TRIAL) has completed
patient enrollment.

 

Coming Soon: Solace Therapeutics will begin enrolling patients in up to
20 clinical sites throughout the USA. 220 women will be eligible to participate
in the trial to test the effectiveness of the Solace Bladder Control Balloon.

To learn more visit: www.stopsui.com